Fundamental Analysis
65 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +60.9% | +71.0% | 3 / 3 | +8.7% | +2.28 pp | +0.92 pp | +4.6% | 1.25 | 6.85 | 311 | +8,7% | 8,8 | +60,9% | 6.85 | 8.78 | −22,0% |
| Pts | 12 | 12 | 12 | 0 | 8 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 4.000 (close price on 2026-10-16)EPS (TTM): 584,2
Financial charts
1.Revenue & growth
VND bn311Q2/26
1.Revenue & growth
VND bn311Q2/26
2.Profit & growth
VND bn8,79Q2/26
3.Profit mix (Penman)
VND bn24,6Q2/26
4.Margins & cost structure
%12.9%Q2/26
5.Returns & cash cycle
% · days4.1%Q2/26
6.Earnings quality & cash
VND bn62,1Q2/26
7.Asset structure
VND bn1.117Q2/26
8.Funding & debt health
VND bn · times1.117Q2/26
9.Revenue backlog
VND bn5,06Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %250Q2/26
Adjusted EPS growth, latest quarter
60.9%
Average adjusted EPS growth, 3 quarters
71.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26